Dublin, Oct. 07, 2021 (GLOBE NEWSWIRE) -- The "Helicobacter Pylori Non-invasive Testing Market Research Report by Test Type, by Test Method, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Helicobacter Pylori Non-invasive Testing Market size was estimated at USD 910.39 Million in 2020 and expected to reach USD 957.09 Million in 2021, at a Compound Annual Growth Rate (CAGR) 5.46% to reach USD 1,253.00 Million by 2026.
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Helicobacter Pylori Non-invasive Testing to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Test Type, the Helicobacter Pylori Non-invasive Testing Market was studied across Serology Test and Stool Antigen Test.
- Based on End-User, the Helicobacter Pylori Non-invasive Testing Market was studied across Clinics and Hospitals.
- Based on Test Method, the Helicobacter Pylori Non-invasive Testing Market was studied across Laboratory-Based Tests and Point-of-care Tests.
- Based on Region, the Helicobacter Pylori Non-invasive Testing Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Helicobacter Pylori Non-invasive Testing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Helicobacter Pylori Non-invasive Testing Market, including Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Inc., Biomerica, Inc., Certest Biotec SL, CorisBioconcept SPRL, DiaSorin S.P.A., Exalenz Bioscience Ltd, Medline Industries, Inc., Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, LLC, Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd., Siemens Healthcare Private Limited, and Thermo Fisher Scientific, Inc.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Helicobacter Pylori Non-invasive Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Helicobacter Pylori Non-invasive Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Helicobacter Pylori Non-invasive Testing Market?
4. What is the competitive strategic window for opportunities in the Global Helicobacter Pylori Non-invasive Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Helicobacter Pylori Non-invasive Testing Market?
6. What is the market share of the leading vendors in the Global Helicobacter Pylori Non-invasive Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Helicobacter Pylori Non-invasive Testing Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of Helicobacter pylori bacterial infection
5.1.1.2. Rising prevalence of gastric ulcer
5.1.1.3. Increasing awareness regarding infection by the government for proper diagnosis
5.1.2. Restraints
5.1.2.1. Low diagnosis rates even in high prevalence geographies
5.1.3. Opportunities
5.1.3.1. Availability of new and advanced non-invasive tests such as real-time PCR and Chemiluminescence Immunoassay (CLIA)
5.1.3.2. Growing demand for point of care testing devices
5.1.4. Challenges
5.1.4.1. Asymptomatic nature of the infection, and stringent regulatory norms
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. Helicobacter Pylori Non-invasive Testing Market, by Test Type
6.1. Introduction
6.2. Serology Test
6.3. Stool Antigen Test
7. Helicobacter Pylori Non-invasive Testing Market, by End-User
7.1. Introduction
7.2. Clinics
7.3. Hospitals
8. Helicobacter Pylori Non-invasive Testing Market, by Test Method
8.1. Introduction
8.2. Laboratory-Based Tests
8.3. Point-of-care Tests
9. Americas Helicobacter Pylori Non-invasive Testing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Helicobacter Pylori Non-invasive Testing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Thailand
11. Europe, Middle East & Africa Helicobacter Pylori Non-invasive Testing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Alere Inc.
13.3. Bio-Rad Laboratories, Inc.
13.4. Biomerica, Inc.
13.5. Certest Biotec SL
13.6. CorisBioconcept SPRL
13.7. DiaSorin S.P.A.
13.8. Exalenz Bioscience Ltd
13.9. Medline Industries, Inc.
13.10. Meridian Bioscience Inc.
13.11. Quidel Corporation
13.12. Sekisui Diagnostics, LLC
13.13. Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.
13.14. Siemens Healthcare Private Limited
13.15. Thermo Fisher Scientific, Inc
14. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/yubfnk
